Wegovy vs Saxenda: Which GLP-1 Medication Is Right for You?

If you're considering a GLP-1 medication for weight loss, you've likely come across both Wegovy and Saxenda. Both are FDA-approved prescription medications that work similarly in your body, but they're not quite the same. Understanding the differences between these two options can help you have a more informed conversation with your healthcare provider about which might be the better fit for your situation.

Let's break down what makes each medication unique, how they compare in real-world results, and what you should consider when deciding between them.

What Are Wegovy and Saxenda?

Both Wegovy and Saxenda belong to a class of medications called GLP-1 receptor agonists. They work by mimicking a natural hormone in your body that helps regulate blood sugar and appetite.

Wegovy contains semaglutide as its active ingredient and was FDA-approved for weight management in 2021. Saxenda contains liraglutide and received FDA approval for weight loss back in 2014, making it the first GLP-1 medication specifically approved for chronic weight management.

While they work through the same mechanism—activating GLP-1 receptors to reduce hunger and increase feelings of fullness—the key differences lie in how they're dosed and how long they stay active in your system.

The Major Differences Between Wegovy and Saxenda

Dosing Schedule

This is where you'll notice the biggest practical difference in your daily life.

Saxenda requires a daily injection. You'll start at a low dose of 0.6 mg and gradually increase over five weeks to the maintenance dose of 3 mg daily. This means you're administering the medication every single day.

Wegovy, on the other hand, is a once-weekly injection. You begin at 0.25 mg weekly and increase gradually over several months until reaching the maintenance dose of 2.4 mg once per week.

For many people, the convenience of a weekly injection versus a daily one is a significant factor in their decision.

Weight Loss Results

Clinical trials show that Wegovy typically leads to more significant weight loss than Saxenda.

In the landmark trials, participants using Wegovy lost an average of 15-17% of their body weight over 68 weeks when combined with lifestyle changes. Saxenda users in their trials lost an average of 8-9% of their body weight over 56 weeks.

It's important to remember that these are averages. Individual results vary based on many factors including starting weight, adherence to the medication, lifestyle modifications, and metabolic differences. Some people respond beautifully to Saxenda, while others may find Wegovy more effective.

How Long They Stay in Your System

Semaglutide (Wegovy) has a much longer half-life than liraglutide (Saxenda)—about one week compared to 13 hours. This is why Wegovy only needs to be taken once weekly while Saxenda requires daily dosing.

This longer-acting nature of Wegovy may contribute to its enhanced effectiveness, as it provides more consistent GLP-1 receptor activation throughout the week.

Side Effects: What to Expect

Because both medications work the same way, they share similar side effects. The most common ones include nausea, diarrhea, constipation, vomiting, and abdominal discomfort.

These side effects are typically most noticeable when you first start the medication or increase your dose. They often improve over time as your body adjusts.

Some people find that the daily dosing of Saxenda allows for more gradual adjustment, while others prefer Wegovy's once-weekly approach. There's no clear winner here—it depends on how your individual body responds.

Both medications carry similar warnings about potential risks including pancreatitis, gallbladder problems, and thyroid tumors (seen in animal studies). Your doctor will review your medical history to ensure either medication is safe for you.

Considerations for Women

Women should know that both medications are not recommended during pregnancy or breastfeeding. If you're planning to become pregnant, you should discontinue Wegovy at least two months before trying to conceive due to its longer half-life, while Saxenda clears your system more quickly.

Some women report that GLP-1 medications affect their menstrual cycles or hormone levels, particularly if significant weight loss occurs. This is worth discussing with your healthcare provider.

Cost and Insurance Coverage

Both Wegovy and Saxenda are expensive medications when paying out of pocket—often over $1,000 per month at list price.

Insurance coverage varies widely. Some plans cover one but not the other, and many require prior authorization or proof that you've tried other weight loss methods first. Coverage has been expanding as more insurers recognize obesity as a chronic medical condition.

Because of cost and supply challenges with brand-name medications, many people are turning to compounded versions of semaglutide, which contain the same active ingredient as Wegovy but at a more accessible price point.

Which One Should You Choose?

There's no universal answer. The right choice depends on your preferences, medical history, and how your body responds.

You might lean toward Saxenda if you prefer the flexibility of daily dosing or if you've had good results with shorter-acting medications in the past. The daily injection allows for more frequent dose adjustments if needed.

Wegovy might be better if you want the convenience of weekly dosing and are looking for potentially greater weight loss results based on clinical trial data.

Your doctor will consider factors like your BMI, any weight-related health conditions, other medications you're taking, and your personal preferences when making a recommendation.

From the Ozari Care Team

In our clinical experience, the best GLP-1 medication is the one you'll actually stick with long-term. Both Wegovy and Saxenda can be highly effective when combined with sustainable lifestyle changes. Remember that these medications work best as part of a comprehensive approach that includes nutrition, movement, and behavioral support—not as a standalone solution.

Ready to Start Your Weight Loss Journey?

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

---

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026